About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials | 4,789 Studies Recruiting

Clinical TrialsPancreatic Cancer

Pancreatic Cancer Clinical Trials

Browse 4,789 clinical trials for pancreatic cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3881-3900 of 4,789 trials

RecruitingTamoxifen for Advanced Solid Pseudopapillary Tumor of the PancreasTamoxifen for Solid Pseudopapillary Tumor of the PancreasNCT06914674·Shanghai CompletedBiweekly SOLAR, as First-line C/T in Pts With Gastric, Pancreatic and Biliary CancersThe primary purpose of the study is to determine the maximal tolerated dose (MTD) of Oxaliplatin in this phase I study.NCT03162510·Taipei CompletedThe Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant TumorsHere's a polished version of the text: "This project involves patients with high-expression LRRC15 malignant tumors who are either clinically suspected of or diagnosed with…NCT07651020·Wuhan, Hubei UnknownConcurrent Chemo-radiotherapy With Capecitabine for Unresectable Locally Advanced Pancreatic CarcinomaThe only curative option for pancreatic cancer patients is surgery, but the patients within 20% of them are possible for a radical surgery.NCT00658840·Goyang-si, Gyeonggi-do

Related Searches

pancreas cancertrials

Data from ClinicalTrials.govTerms

RecruitingA Tailored, Web-based Program (COMPASS) to Improve Exercise and Dietary Changes in Stage I-III Pancreatic Cancer Patients Receiving Neoadjuvant ChemotherapyThis clinical trial studies whether a tailored, web-based program (web portal), Community for Physical Activity and Supportive Nutrition Strategies (COMPASS), can be used to…NCT07651358·Portland, Oregon

UnknownPredictive Factors for Resection and Survival in Type A Borderline Resectable Pancreatic Ductal Adenocarcinoma Patients After Neoadjuvant TherapyRadical surgical resection is the only curative treatment option for pancreatic cancer, but borderline resectable tumors have a high probability of incomplete exeresis.NCT05489458

CompletedSBRT for Close or Positive Margins After Resection of Pancreatic AdenocarcinomaThe current study seeks to further investigate the impact of Stereotactic Body Radiation Therapy following pancreatic resection with a close or positive margin.NCT01357525·Pittsburgh, Pennsylvania

UnknownOpen Label Immunotherapy Trial of Inoperable Pancreatic CancerPancreatic cancer (PDA) is the most lethal form of cancer, and the fourth-leading cause of cancer-related death in the United States, with a survival rate of less than 7%.There…NCT03165591·Ulaanbaatar and 1 other

TerminatedMitomycin C and Ifosfamide in Treating Patients With Metastatic Pancreatic CancerRATIONALE: Drugs used in chemotherapy, such as mitomycin C and ifosfamide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping…NCT00967291·Milan

Not yet recruitingIrinotecan Liposome for Resectable Pancreatic Cancer With or Without AddebelizumabTo evaluate the efficacy and safety of irinotecan liposomes with oxaliplatin, 5-fluorouracil (5-FU) / leucovorin (LV) with or without adelizumab for resectable pancreatic cancer…NCT06172036

TerminatedDeveloping Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung DisordersThe goal of this research is to optimize the MRI system to obtain ideal lung images using Hyperpolarized (HP) Noble and Inert Fluorinated Gases as contrast agents.NCT02748798·Thunder Bay, Ontario

RecruitingClinical Study of Lewis Antigen Assay Combined With CA19-9 Assay to Assess Prognosis in Patients With Pancreatic CancerCA19-9 is an acidic glycoside containing sialic acid, called ganglioside.NCT06515587·Shanghai, Shanghai Municipality

CompletedComparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CTThis clinical trial studies gallium Ga 68-edotreotide positron emission tomography (PET)/computed tomography (CT) compared with indium In 111 pentetreotide plus contrast-enhanced…NCT01869725·Iowa City, Iowa

UnknownClinical Evaluation of 68Ga-NOTA-MAL-Cys39-exendin-4 Positron Emission Tomography in the Detection of InsulinomaGlucagon-like peptide-1 receptor (GLP-1R) is a kind of G protein coupled receptor which regulate the insulin secretion and serves as potential target in the diagnosis of…NCT04185350·Nanjing, Jiangsu

CompletedStudy to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia.Study to assess the safety and tolerability of repeated doses of an investigational new drug in patients with cancer and cachexia.NCT04299048·Beverly Hills, California and 9 others

WithdrawnDovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic CancerThis phase I trial studies the highest and safest doses of dovitinib lactate, paclitaxel albumin-stabilized nanoparticle formulation, and gemcitabine hydrochloride when given…NCT02048943·Buffalo, New York

RecruitingUlixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid TumorsThis phase I study is designed to establish the safety, maximally tolerated dose (MTD) and recommended phase II dose (RP2D) of the ERK inhibitor ulixertinib (BVD-523) when…NCT03454035·Chapel Hill, North Carolina

CompletedPhase I Study to evaluate124I-A11 PSCA Minibody in Patients With Metastatic Prostate, Bladder and Pancreatic CancerThe purpose of the study is to determine whether positron emission tomography (PET), using the new imaging drug \[124 I\] PSCA-Minibody can be used for imaging prostate…NCT02092948·Los Angeles, California

UnknownA Preoperative Model to Predict the Lymphovascular Invasion in Pancreatic Ductal AdenocarcinomaImportance: Lymphovascular invasion (LVI) is a poor prognosis pathologic feature in pancreatic ductal adenocarcinoma (PDAC) patients.NCT05997147·Tianjin, Tianjin Municipality

CompletedGene Therapy of Pancreatic Ductal AdenocarcinomaNear 85% of patients with pancreatic adenocarcinoma are diagnosed with a locally advanced and/or metastatic unresectable tumor.NCT01274455·Toulouse

PreviousPage 195 of 240Next